Skip to main content
Erschienen in: Journal of Public Health 6/2017

06.07.2017 | Overview

Transition from HIV control to HIV elimination in Switzerland

verfasst von: T. A. Haakma, S. Luder, E. Müller, B. Somaini

Erschienen in: Journal of Public Health | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This article proposes a strategy for Switzerland to change the goal from HIV control to HIV elimination. In Switzerland, HIV treatment is well organized and available for all with good access.

Methods

An important challenge that obstructs prevention is the new infections originating from people who are unaware of their status. Since the majority of new infections in Switzerland are within the group of men who have sex with men (MSM), this strategy targets MSM who do not know their HIV status and engage in risky sexual behavior.

Results

The strategy focuses on three pillars: collaboration and leadership, key actions and important indicators. To guide this effort, we proposed a task force to be responsible for leading this strategy. Its actions are centered around four aspects: learn from MSM, promote and facilitate testing, and include PrEP and PEP in the prevention package together with partner information. This article also provides important indicators that must be measured to inform the task force and to adapt or strengthen the strategy to reach the goal.

Conclusion

Reaching the right persons and offering the right “prevention package” are the key challenges for Switzerland to be among the first countries to eliminate HIV transmission.
Glossar
ART
Antiretroviral therapy, the current treatment for HIV-infected people. It reduces the virus to undetectable levels in nearly all patients.
FCSH
Federal Commission for Sexual Health
FOPH
Federal Office of Public Health Switzerland, part of the Federal Department of Home Affairs, has responsibility for public health and development of health policies in Switzerland.
MSM
Men who have sex with men.
PEP
Post-exposure prophylaxis, an oral chemoprophylaxis, is intended to serve as an emergency measure by taking anti-retroviral drugs for about 28 days after having a risky sexual encounter to prevent HIV.
PrEP
Pre-exposure prophylaxis, another oral chemoprophylaxis, is intended for people who regularly engage in sexual risky encounters by daily use of antiretroviral drugs. It should be taken for a sufficient length of time before and after risky sexual behavior to prevent HIV.
STI
Sexually transmitted infection
Literatur
Zurück zum Zitat Allman D, Xu K, Myers T, Aguinaldo J, Calzavara L, Maxwell J, Burchell A, Remis RS (2009) Delayed application of condoms with safer and unsafe sex: factors associated with HIV risk in a community sample of gay and bisexual men. AIDS Care 21:775–784CrossRefPubMed Allman D, Xu K, Myers T, Aguinaldo J, Calzavara L, Maxwell J, Burchell A, Remis RS (2009) Delayed application of condoms with safer and unsafe sex: factors associated with HIV risk in a community sample of gay and bisexual men. AIDS Care 21:775–784CrossRefPubMed
Zurück zum Zitat amfAR (2013) Fact sheet emerging HIV prevention technologies for gay men, other men who have sex with men and transgender individuals (GMT). amfAR, The Foundation for AIDS Research, New York amfAR (2013) Fact sheet emerging HIV prevention technologies for gay men, other men who have sex with men and transgender individuals (GMT). amfAR, The Foundation for AIDS Research, New York
Zurück zum Zitat Baggaley RF, White RG, Boily M-C (2010) HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 39(4):1048–1063 Baggaley RF, White RG, Boily M-C (2010) HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 39(4):1048–1063
Zurück zum Zitat Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH (2016) Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med 375:830–839CrossRefPubMedPubMedCentral Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH (2016) Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med 375:830–839CrossRefPubMedPubMedCentral
Zurück zum Zitat Conniff J, Evensen A (2016) Preexposure prophylaxis (PrEP) for HIV prevention: the primary care perspective. The Journal of the American Board of Family Medicine 29:143–151CrossRefPubMed Conniff J, Evensen A (2016) Preexposure prophylaxis (PrEP) for HIV prevention: the primary care perspective. The Journal of the American Board of Family Medicine 29:143–151CrossRefPubMed
Zurück zum Zitat Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, Mayer KH, McGowan I, Carballo-Diéguez A (2015) Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev 27:289–297CrossRefPubMedPubMedCentral Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, Mayer KH, McGowan I, Carballo-Diéguez A (2015) Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev 27:289–297CrossRefPubMedPubMedCentral
Zurück zum Zitat Du Bois SN, Emerson E, Mustanski B (2011) Condom-related problems among a racially diverse sample of young men who have sex with men. AIDS Behav 15:1342–1346CrossRefPubMed Du Bois SN, Emerson E, Mustanski B (2011) Condom-related problems among a racially diverse sample of young men who have sex with men. AIDS Behav 15:1342–1346CrossRefPubMed
Zurück zum Zitat Federal Commission for Sexual Health (FCSH) (2016) Recommendations of the Swiss Federal Commission for Sexual Health (FCSH) on pre-exposure prophylaxis (PrEP) for HIV prevention. Swiss Federal Commission for Sexual Health, Switzerland Federal Commission for Sexual Health (FCSH) (2016) Recommendations of the Swiss Federal Commission for Sexual Health (FCSH) on pre-exposure prophylaxis (PrEP) for HIV prevention. Swiss Federal Commission for Sexual Health, Switzerland
Zurück zum Zitat Federal Office of Public Health (FOPH) (2010) National programme on HIV and other STI (NPHS) 2011–2017. Swiss Federal Office of Public Health, Bern Federal Office of Public Health (FOPH) (2010) National programme on HIV and other STI (NPHS) 2011–2017. Swiss Federal Office of Public Health, Bern
Zurück zum Zitat Federal Office of Public Health (FOPH) (2012) UNGASS country progress report 2012 Switzerland. Swiss Federal Office of Public Health, Bern Federal Office of Public Health (FOPH) (2012) UNGASS country progress report 2012 Switzerland. Swiss Federal Office of Public Health, Bern
Zurück zum Zitat Federal Office of Public Health (FOPH) (2016) HIV und Aids in der Schweiz im Jahr 2015 vol 46. FOPH, Bern Federal Office of Public Health (FOPH) (2016) HIV und Aids in der Schweiz im Jahr 2015 vol 46. FOPH, Bern
Zurück zum Zitat FHI (2009) Monitoring and evaluation indicators for MSM HIV prevention and care services in Thailand. FHI, Thailand, p 360 FHI (2009) Monitoring and evaluation indicators for MSM HIV prevention and care services in Thailand. FHI, Thailand, p 360
Zurück zum Zitat Gottschalk J, Achermann Y, Niederhauser C, Tinguely C, Glauser A, Lodemann P, Frey BM (2010) First case of HIV window donation in Switzerland after 8 years of universal HIV NAT screening. Blutspende Zürich, Interlaken Gottschalk J, Achermann Y, Niederhauser C, Tinguely C, Glauser A, Lodemann P, Frey BM (2010) First case of HIV window donation in Switzerland after 8 years of universal HIV NAT screening. Blutspende Zürich, Interlaken
Zurück zum Zitat Gumy C, Jeannin A, Balthasar H, Huissoud T, Jobin V, Häusermann M, Crevoisier H, Sudre P, Dubois-Arber F (2012) Five-year monitoring of a gay-friendly voluntary counselling and testing facility in Switzerland: who got tested and why? BMC Public Health 12:1CrossRef Gumy C, Jeannin A, Balthasar H, Huissoud T, Jobin V, Häusermann M, Crevoisier H, Sudre P, Dubois-Arber F (2012) Five-year monitoring of a gay-friendly voluntary counselling and testing facility in Switzerland: who got tested and why? BMC Public Health 12:1CrossRef
Zurück zum Zitat Heuer C (2014) Midterm-Check (MTC) Nationales Programm HIV und andere sexuell übertragbare Infektionen (NPHS) 2011–2017. Schweizerische Eidgenossenschaft, Bern Heuer C (2014) Midterm-Check (MTC) Nationales Programm HIV und andere sexuell übertragbare Infektionen (NPHS) 2011–2017. Schweizerische Eidgenossenschaft, Bern
Zurück zum Zitat Heusser P, Suter C, Bachmann D, Steinmann C (2013) Rechtsratgeber HIV; Alles, was Sie zu HIV und Recht wissen müssen. AIDS Help Switzerland, Zurich Heusser P, Suter C, Bachmann D, Steinmann C (2013) Rechtsratgeber HIV; Alles, was Sie zu HIV und Recht wissen müssen. AIDS Help Switzerland, Zurich
Zurück zum Zitat Hickson F, Nutland W, Weatherburn P, Burnell C, Keogh M, Doyle T, Watson R, Gault A (2003) Making it count—a collaborative planning framework to reduce the incidence of HIV infection during sex between men. Sigma Research, London Hickson F, Nutland W, Weatherburn P, Burnell C, Keogh M, Doyle T, Watson R, Gault A (2003) Making it count—a collaborative planning framework to reduce the incidence of HIV infection during sex between men. Sigma Research, London
Zurück zum Zitat Jamil MS, Prestage G, Fairley CK, Grulich AE, Smith KS, Chen M, Holt M, McNulty AM, Bavinton BR, Conway DP (2017). Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trial. The lancet HIV 4(6):e241–e250 Jamil MS, Prestage G, Fairley CK, Grulich AE, Smith KS, Chen M, Holt M, McNulty AM, Bavinton BR, Conway DP (2017). Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trial. The lancet HIV 4(6):e241–e250
Zurück zum Zitat Kohler P, Schmidt AJ, Cavassini M, Furrer H, Calmy A, Battegay M, Bernasconi E, Ledergerber B, Vernazza P, SHC S (2015) The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV. AIDS 29:2509–2515CrossRefPubMed Kohler P, Schmidt AJ, Cavassini M, Furrer H, Calmy A, Battegay M, Bernasconi E, Ledergerber B, Vernazza P, SHC S (2015) The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV. AIDS 29:2509–2515CrossRefPubMed
Zurück zum Zitat Krakower DS, Jain S, Mayer KH (2015) Antiretrovirals for primary HIV prevention: the current status of pre-and post-exposure prophylaxis. Current HIV/AIDS Reports 12:127–138CrossRefPubMedPubMedCentral Krakower DS, Jain S, Mayer KH (2015) Antiretrovirals for primary HIV prevention: the current status of pre-and post-exposure prophylaxis. Current HIV/AIDS Reports 12:127–138CrossRefPubMedPubMedCentral
Zurück zum Zitat Kübler D, Low N, Brunold H, Elford J, Hughes G, Rosenbrock R (2015) Fourth report of the surveillance working Group Federal Commission for Sexual Health. Federal Commission for Sexual Health, Zurich Kübler D, Low N, Brunold H, Elford J, Hughes G, Rosenbrock R (2015) Fourth report of the surveillance working Group Federal Commission for Sexual Health. Federal Commission for Sexual Health, Zurich
Zurück zum Zitat Laar AK, DeBruin DA, Craddock S (2015) Partner notification in the context of HIV: an interest-analysis. AIDS Res Ther 12:1CrossRef Laar AK, DeBruin DA, Craddock S (2015) Partner notification in the context of HIV: an interest-analysis. AIDS Res Ther 12:1CrossRef
Zurück zum Zitat Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ (2013) A systematic review and meta-regression of temporal trends in adult CD4+ cell count at presentation to HIV care, 1992–2011. Clin Infect Dis 57(7):1027–1037 Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ (2013) A systematic review and meta-regression of temporal trends in adult CD4+ cell count at presentation to HIV care, 1992–2011. Clin Infect Dis 57(7):1027–1037
Zurück zum Zitat Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A (2016) Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Global Health 1:e000010CrossRefPubMedPubMedCentral Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A (2016) Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Global Health 1:e000010CrossRefPubMedPubMedCentral
Zurück zum Zitat Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, Colfax G, Pathak S, Gvetadze R, O’Hara B (2013) Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States. J Acquir Immune Defic Syndr 64(1999):87CrossRefPubMedPubMedCentral Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, Colfax G, Pathak S, Gvetadze R, O’Hara B (2013) Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States. J Acquir Immune Defic Syndr 64(1999):87CrossRefPubMedPubMedCentral
Zurück zum Zitat Montoy JCC, Dow WH, Kaplan BC (2016) Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial. BMJ 352:h6895CrossRefPubMedCentral Montoy JCC, Dow WH, Kaplan BC (2016) Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial. BMJ 352:h6895CrossRefPubMedCentral
Zurück zum Zitat Mustanski BS, Newcomb ME, Du Bois SN, Garcia SC, Grov C (2011) HIV in young men who have sex with men: a review of epidemiology, risk and protective factors, and interventions. Journal of sex research 48:218–253CrossRefPubMedPubMedCentral Mustanski BS, Newcomb ME, Du Bois SN, Garcia SC, Grov C (2011) HIV in young men who have sex with men: a review of epidemiology, risk and protective factors, and interventions. Journal of sex research 48:218–253CrossRefPubMedPubMedCentral
Zurück zum Zitat Nodin N, Carballo-Dieguez A, Ventuneac AM, Balan IC, Remien R (2008) Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care 20:106–115CrossRefPubMed Nodin N, Carballo-Dieguez A, Ventuneac AM, Balan IC, Remien R (2008) Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care 20:106–115CrossRefPubMed
Zurück zum Zitat Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A (2016) Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 316:171–181CrossRefPubMed Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A (2016) Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 316:171–181CrossRefPubMed
Zurück zum Zitat Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR (2012) Condom use errors and problems: a global view. Sex Health 9:81–95CrossRefPubMed Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR (2012) Condom use errors and problems: a global view. Sex Health 9:81–95CrossRefPubMed
Zurück zum Zitat Shilaih M, Marzel A, Braun DL, Scherrer AU, Kovari H, Young J, Calmy A, Darling K, Battegay M, Hoffmann M (2017) Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine 96:e5849CrossRefPubMedPubMedCentral Shilaih M, Marzel A, Braun DL, Scherrer AU, Kovari H, Young J, Calmy A, Darling K, Battegay M, Hoffmann M (2017) Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine 96:e5849CrossRefPubMedPubMedCentral
Zurück zum Zitat Venter F, Allais L, Richter M (2014) Exposure ethics: does Hiv pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker? Bioethics 28:269–274CrossRefPubMed Venter F, Allais L, Richter M (2014) Exposure ethics: does Hiv pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker? Bioethics 28:269–274CrossRefPubMed
Metadaten
Titel
Transition from HIV control to HIV elimination in Switzerland
verfasst von
T. A. Haakma
S. Luder
E. Müller
B. Somaini
Publikationsdatum
06.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Public Health / Ausgabe 6/2017
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-017-0819-y

Weitere Artikel der Ausgabe 6/2017

Journal of Public Health 6/2017 Zur Ausgabe